Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: The ARGENTO Study: A prospective, multicenter registry

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 757-761

  Cassese, Salvatore ^a   Galasso, Gennaro ^a   Sciahbasi, Alessandro ^b   Scacciatella, Paolo ^c   Muçaj, Andi ^d   Piccolo, Raffaele ^a   D'Anna, Carolina ^a   Pangrazi, Alberta ^d   Lioy, Ernesto ^b   Marra, Sebastiano ^c   Piscione, Federico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Antiplatelet therapy; Genous; Non cardiac surgery; Percutaneous coronary intervention; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE SAFETY; DIABETES MELLITUS; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX; STENT THROMBOSIS; THERAPY EFFECT;

ANTIPLATELET THERAPY; GENOUS; NON-CARDIAC SURGERY; PERCUTANEOUS CORONARY INTERVENTION; STENT;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; STENTS; TREATMENT OUTCOME;

EID: 84880917570     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.052     Document Type: Article

References (33)

1. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
2. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) J Am Coll Cardiol 47 2006 e1 e121
3. S.H. Wilson, P. Fasseas, and J.L. Orford Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting J Am Coll Cardiol 42 2003 234 240
4. F. Airoldi, A. Colombo, and N. Morici Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
5. G.Y. Lip, B.S. Chin, and A.D. Blann Cancer and the prothrombotic state Lancet Oncol 3 2002 27 34
6. D. Poldermans, J.J. Bax, and E. Boersma Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery Eur Heart J 30 2009 2769 2812
7. E.S. Brilakis, J.L. Orford, and P. Fasseas Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery Am J Cardiol 96 2005 512 514
8. N. Werner, S. Junk, and U. Laufs Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury Circ Res 93 2003 e17 e24
9. J. Aoki, P.W. Serruys, and H. van Beusekom Endothelial progenitor cell capture by stents coated with antibody against CD34: the healing-fim (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry J Am Coll Cardiol 45 2005 1574 1579
10. H.J. Duckers, T. Soullie, and P. den Heijer Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II Trial using an endothelial progenitor cell capturing stent (genous R stent) EuroIntervention 3 2007 350 358
11. M. Co, E. Tay, and C.H. Lee Use of endothelial progenitor cell capture stent (genous bio-engineered R stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up Am Heart J 155 2008 128 132
12. P. Damman, M. Klomp, and M.A. Beijk Twelve-month outcomes after coronary stenting with the genous bio-engineered R stent in diabetic patients from the e-healing registry J Interv Cardiol 24 2011 285 294
13. P. Damman, M. Klomp, and S. Silber Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous bio-engineered R stent in patients from the e-healing registry Catheter Cardiovasc Interv 79 2012 243 252
14. S. Silber, P. Albertsson, and F.F. Aviles Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology Eur Heart J 26 2005 804 847
15. F. Piscione, S. Cassese, and G. Galasso A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery Int J Cardiol 146 2011 399 403
16. P.J. de Feyter, P.W. Serruys, M.J. Davies, P. Richardson, J. Lubsen, and M.F. Oliver Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials Circulation 84 1991 412 423
17. M. Vasa, S. Fichtlscherer, and K. Adler Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease Circulation 103 2001 2885 2890
18. The GUSTO Investigators GUSTO. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 1993 673 682
19. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
20. S. Halabi, and B. Singh Sample size determination for comparing several survival curves with unequal allocations Stat Med 23 2004 1793 1815
21. C. Briguori, A. Colombo, and F. Airoldi Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease Am Heart J 150 2005 807 813
22. J.W. van Werkum, A.A. Heestermans, and A.C. Zomer Predictors of coronary stent thrombosis: the dutch stent thrombosis registry J Am Coll Cardiol 53 2009 1399 1409
23. A.C. To, G. Armstrong, I. Zeng, and M.W. Webster Noncardiac surgery and bleeding after percutaneous coronary intervention Circulation 2 2009 213 221
24. A. Verdecchia, R. De Angelis, S. Francisci, and E. Grande Methodology for estimation of cancer incidence, survival and prevalence in italian regions Tumori 93 2007 337 344
25. W.A. Ghali, H. Quan, and R. Brant Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models JAMA 286 2001 1494 1497
26. E. Boersma, M.D. Kertai, and O. Schouten Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee Cardiac Risk Index Am J Med 118 2005 1134 1141
27. S. Silber, P. Damman, and M. Klomp Clinical results after coronary stenting with the genous bio-engineered R stent: 12-month outcomes of the e-healing (healthy endothelial accelerated lining inhibits neointimal growth) worldwide registry EuroIntervention 6 2011 819 825
28. K. Larsen, C. Cheng, and D. Tempel Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model Eur Heart J 33 2012 120 128
29. G.M. Sangiorgi, M.C. Morice, and E. Bramucci Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after genous bio-engineered R stent implantation: the multicentre pilot genous trial EuroIntervention 7 2011 813 819
30. P. Scacciatella, E. Meliga, and M. D'Amico Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registry EuroIntervention 6 2011 826 830
31. M.J. Eisenberg, P.R. Richard, D. Libersan, and K.B. Filion Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents Circulation 119 2009 1634 1642
32. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
33. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420